Switch theme
Sign up to access all valuation multiples
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
2011
202
LTM Revenue $28.6M
LTM EBITDA -$28.8M
$29.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
DarioHealth has a last 12-month revenue of $28.6M and a last 12-month EBITDA of -$28.8M.
In the most recent fiscal year, DarioHealth achieved revenue of $27.0M and an EBITDA of -$50.3M.
DarioHealth expects next 12-month revenue of XXX and NTM EBITDA of XXX
See DarioHealth valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $20.4M | $27.0M | XXX | XXX | XXX |
| Gross Profit | $9.7M | $6.0M | XXX | XXX | XXX |
| Gross Margin | 47% | 22% | XXX | XXX | XXX |
| EBITDA | -$54.4M | -$50.3M | XXX | XXX | XXX |
| EBITDA Margin | -267% | -186% | XXX | XXX | XXX |
| Net Profit | -$62.2M | -$59.4M | XXX | XXX | XXX |
| Net Margin | -306% | -220% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, DarioHealth's stock price is $1.
DarioHealth has current market cap of $28.0M, and EV of $29.7M.
See DarioHealth trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $29.7M | $28.0M | XXX | XXX | XXX | XXX | $-0.51 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, DarioHealth has market cap of $28.0M and EV of $29.7M.
DarioHealth's trades at 1.0x LTM EV/Revenue multiple, and -1.0x LTM EBITDA.
Analysts estimate DarioHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for DarioHealth and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $29.7M | XXX | XXX | XXX |
| EV/Revenue | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | -0.6x | XXX | XXX | XXX |
| P/E | -0.7x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -0.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpDarioHealth's NTM/LTM revenue growth is 20%
DarioHealth's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.4M for the same period.
Over next 12 months, DarioHealth's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate DarioHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for DarioHealth and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 33% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -186% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -7% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -166% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 97% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 76% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 89% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 263% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedAdvisor | XXX | XXX | XXX | XXX | XXX | XXX |
| Oneview Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Life Semantics | XXX | XXX | XXX | XXX | XXX | XXX |
| Kooth | XXX | XXX | XXX | XXX | XXX | XXX |
| Alignment Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
DarioHealth acquired XXX companies to date.
Last acquisition by DarioHealth was XXXXXXXX, XXXXX XXXXX XXXXXX . DarioHealth acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was DarioHealth founded? | DarioHealth was founded in 2011. |
| Where is DarioHealth headquartered? | DarioHealth is headquartered in United States of America. |
| How many employees does DarioHealth have? | As of today, DarioHealth has 202 employees. |
| Who is the CEO of DarioHealth? | DarioHealth's CEO is Mr. Erez Raphael. |
| Is DarioHealth publicy listed? | Yes, DarioHealth is a public company listed on NAS. |
| What is the stock symbol of DarioHealth? | DarioHealth trades under DRIO ticker. |
| When did DarioHealth go public? | DarioHealth went public in 2013. |
| Who are competitors of DarioHealth? | Similar companies to DarioHealth include e.g. MedAdvisor, Oneview Healthcare, Life Semantics, Kooth. |
| What is the current market cap of DarioHealth? | DarioHealth's current market cap is $28.0M |
| What is the current revenue of DarioHealth? | DarioHealth's last 12-month revenue is $28.6M. |
| What is the current EBITDA of DarioHealth? | DarioHealth's last 12-month EBITDA is -$28.8M. |
| What is the current EV/Revenue multiple of DarioHealth? | Current revenue multiple of DarioHealth is 1.0x. |
| What is the current EV/EBITDA multiple of DarioHealth? | Current EBITDA multiple of DarioHealth is -1.0x. |
| What is the current revenue growth of DarioHealth? | DarioHealth revenue growth between 2023 and 2024 was 33%. |
| Is DarioHealth profitable? | Yes, DarioHealth is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
